EU medicines agencies reflect on lessons learned from COVID-19 – www.ema.europa.eu

1 Dic, 2023

www.ema.europa.eu

The European Medicines Regulatory Network (EMRN) has been at the forefront of the fight against COVID-19 with its crucial role in the evaluation and monitoring of medicines, including vaccines. A joint report issued by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) reviews the Network’s response and highlights the main learnings for any future health crises.

Vai all’articolo completo.